Search

Gonadorelin

Gonadorelin is another name for gonadotropin-releasing hormone (GnRH). It is a synthetic decapeptide prepared using solid phase peptide synthesis. GnRH is responsible for the release of follicle stimulating hormone and leutinizing hormon...

Canakinumab

Canakinumab binds to human IL-1β and neutralizes its inflammatory activity by blocking its interaction with IL-1 receptors, but it does not bind IL-1alpha or IL-1 receptor antagonist (IL-1ra). … be safe and effective, offering a considerable advantage over the existing treatment with the human IL-1 receptor antagonist, anakinra, which must be injected daily and which is often poorly tolerated by

Bunamiodyl

Withdrawn from the Canadian, US, and UK markets in 1963 due to nephropathy.

Dantron

Withdrawn from the Canadian, US, and UK markets in 1998 due to genotoxicity.

Oxeladin

Withdrawn from the Canadian, US, and UK markets in 1976 due to carcinogenicity.

Bisphenol A diglycidyl ether

Dipentamethylenethiuram disulfide

N,N'-diphenyl-1,4-phenylenediamine

Eculizumab

[L6919] In Q1 2023, the EMA's Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion of two formulations of eculizumab indicated for the treatment of paroxysmal nocturnal hemoglobinuria

Acetylcarnitine

Acetylcarnitine can be synthesized, but it is also naturally found in adequate amounts in healthy humans.